Cirrus Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2023

Valuation $0–100M

Headcount <100

Total funding $10–50M

Unlock exact values

Company overview

Cirrus Therapeutics company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2023
Headquarters: Cambridge, United States
Employees: 12
Open positions: None listed
Dealroom signal: 0.0

LinkedIn ↗

sub industryPharmaceuticalsub industryBioTechnologyindustryHealthsectorSpinoutsectorDT and LSsectoruk is8 life sciencessectorUKSUsectorUKSU2010sectorscience-based

Valuation & funding

Cirrus Therapeutics funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Aug 2026	$15M	$59M	Polaris Partners · Seeds Capital · ClavystBio	↗
SPINOUT✓Other financing	Dec 2023	$0	—	University of Bristol	—

Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

Year	Employees
2026	12
2025	4

Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Cirrus Therapeutics team growth

Cirrus Therapeutics's team grew 200% over the past year.

1-year team growth+200%

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Cirrus Therapeutics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SBSilvia BioCellular analysis and media for biomanufacturing optimization.	Sheffield, United Kingdom	Operational	4	$3.1M	$663K
SISignaCorSignaCor is a clinical stage, drug development company, dedicated to the treatment of cardiac disease.	Belfast, United Kingdom	Operational
MLMitotype Precision LabsHigh-throughput mitochondrial assays for drug discovery	Sheffield, United Kingdom	Operational
DTDraig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment	Cardiff, United Kingdom	Operational
CHCellestial HealthPioneering brain disease treatment by targeting astrocytic networks with sustainable pharmaceutical practices	Cambridge, United Kingdom	Operational
CTCrucible TherapeuticsRNA-targeting therapies for debilitating neurodegenerative diseases	Sheffield, United Kingdom	Operational
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
TTTay TherapeuticsBiotech platform enhancing patient-specific medicines through advanced discovery and development expertise	Dundee, United Kingdom	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

Cirrus Therapeutics's talent

Book a demo to see the people

Team profiled 3 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Cirrus Therapeutics's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 3 investors entered at this stage

ClavystBio

Polaris Partners

Seeds Capital

Other known 2 additional known investors

University of Bristol

ZAKA VC

Global footprint

Where Cirrus Therapeutics has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States70%

🇸🇬 Singapore20%

🇬🇧 United Kingdom10%

3 countries shown

In the news

Latest news about Cirrus Therapeutics

Recent press, funding announcements, and product moves mentioning Cirrus Therapeutics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Cirrus Therapeutics

An AI-synthesized read of the highest-engagement posts about Cirrus Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cirrus Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.